Formosa Laboratories Inc, based in Taiwan, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is SEVELAMER HYDROCHLORIDE, with a corresponding US DMF Number 22631.
Remarkably, this DMF maintains an Active status since its submission on March 16, 2009, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of September 10, 2013, and payment made on August 29, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II